Quest Diagnostics
DGX
#1094
Rank
โ‚น2.104 T
Marketcap
โ‚น19,008
Share price
-0.56%
Change (1 day)
21.80%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น867.02. In 2025 the company made an earnings per share (EPS) of โ‚น838.66 an increase over its 2024 EPS that were of โ‚น735.60.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-2.29%
2025โ‚น838.6614.01%
2024โ‚น735.602.5%
2023โ‚น717.63-5.83%
2022โ‚น762.07-49.21%
2021โ‚น1,50149.72%
2020โ‚น1,00266.67%
2019โ‚น601.3418%
2018โ‚น509.62-4.26%
2017โ‚น532.3223.19%
2016โ‚น432.09-7.11%
2015โ‚น465.1928.46%
2014โ‚น362.13-31.61%
2013โ‚น529.4860.46%
2012โ‚น329.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,074 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น67.30-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น58.62-106.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น194.78-77.53%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.86-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA